Ropes & Gray represented The Duckhorn Portfolio in the transaction, and Kirkland & Ellis represented Butterfly Equity. Butterfly Equity announced it has entered into a definitive...
Butterfly’s $1.95 Billion Take-Private Acquisition of The Duckhorn Portfolio
L Catterton’s Acquisition of a Majority Stake in [solidcore]
Ropes & Gray represented VMG Partners and [solidcore] in the transaction, and Kirkland & Ellis represented L Catterton. L Catterton announced it has signed a definitive...
MaryRuth Organics’ Acquisition of Stake in Butterfly
Kirkland & Ellis advised Butterfly on the transaction, Latham & Watkins advised MaryRuth Organics, LLC and Fried, Frank, Harris, Shriver & Jacobson advised King Street. Butterfly...
Mars’ $36 Billion Acquisition of Kellanova
Gibson, Dunn & Crutcher is advising Goldman Sachs as financial advisor to Kellanova in the transaction, Skadden, Arps, Slate, Meagher & Flom is advising Mars, with...
Crown Laboratories’ $924 Million Merger with Revance Therapeutics
Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
Thoughtworks’ $1.75 Billion Take-Private by Apax Funds
Kirkland & Ellis LLP and Richards, Layton & Finger, P.A. are acting as legal counsel to Apax. Kramer Levin Naftalis & Frankel LLP and Potter Anderson...
Altaris’ Acquisition of Sharecare
Wachtell, Lipton, Rosen & Katz is acting as legal advisor to Sharecare, while Kirkland & Ellis is acting as legal advisor to Altaris. King & Spalding...
EQT’s $3 Billion Acquisition of Perficient
Simpson Thacher & Bartlett is advising an affiliate of BPEA Private Equity Fund VIII, part of EQT on the transaction, and Kirkland & Ellis is advising...
Ryze Claim’s Recapitalization
McDermott, Will & Emery, and Dowling Hales advised Ryze Claim Solutions on the transaction, and Kirkland & Ellis advised Bain Capital Insurance. Ryze Claim Solutions (Ryze) announced...
AbbVie’s Acquisition of Cerevel Therapeutics
Kirkland & Ellis advised AbbVie, Latham & Watkins advised Cerevel Therapeutics, Skadden advised Centerview partners LLC, as financial advisor to Cerevel Therapeutics in the transaction. AbbVie...
Providence’s Minority Investment in Populous
Kirkland & Ellis is advising Providence Equity Partners on the transaction, and Bryan Cave Leighton Paisner is advising Populous. Providence Equity Partners announced its minority investment in Populous....
Warburg Pincus’ US$1 Billion Investment in Everise
Latham & Watkins advised Warburg Pincus; Kirkland & Ellis acted for Everise. Warburg Pincus, a leading global growth investor, completed a US$1 billion investment in Everise, a leading...